Zobrazeno 1 - 9
of 9
pro vyhledávání: '"398"'
Autor:
Rina Shibayama, Yasuhito Sekimoto, Kazuhisa Takahashi, Takehito Shukuya, Naoko Shimada, Motoyasu Kato, Kota Nakamura, Fumiyuki Takahashi, Osamu Nagashima, Ryo Ko, Ryo Koyama, Shinichi Sasaki, Hiroaki Ihara, Ken Tajima, Keita Mori, Ryota Kanemaru
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Cancer
BMC Cancer
Background Interstitial lung diseases induced by anticancer agents (ILD-AA) are rare adverse effects of anticancer therapy. However, prognostic biomarkers for ILD-AA have not been identified in patients with advanced lung cancer. Our aim was to analy
Autor:
Yingwei Xue, Jia Hong, Xu Han, Wenjing Tian, Lin Zhu, Yashuang Zhao, Jing Wang, Haibo Zhou, Chuang Nie, Anastasiia Leonteva, Xinyu Du, Rongrong Wei
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-10 (2021)
BMC Cancer
BMC Cancer
Background Peripheral blood leukocyte (PBL) DNA methylation may serve as a surrogate marker to evaluate the susceptibility to and prognosis of gastric cancer (GC). In this study, blood-derived DNA methylation levels of two tumour-related genes, namel
Autor:
Yu-De Chu, Rong-Nan Chien, Po-Yuan Ke, Ming-Wei Lai, Tai-Long Pan, Kwang-Hui Lin, Chau-Ting Yeh, Ta-Sen Yeh, Chih-Lang Lin
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
BMC Cancer
BMC Cancer
Background Although men carry a higher risk of hepatocellular carcinoma (HCC) than women, it is still controversial whether men also have a poorer postoperative prognosis. A retrospective study was conducted to evaluate the postoperative prognostic p
Autor:
Alex C. Harris, Deborah W. Knapp, Heidi G. Parker, Elaine A. Ostrander, Deepika Dhawan, José A. Ramos-Vara, Brian W. Davis
Publikováno v:
BMC Cancer
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
BMC Cancer, Vol 20, Iss 1, Pp 1-12 (2020)
Background Invasive urothelial carcinoma (iUC) is highly similar between dogs and humans in terms of pathologic presentation, molecular subtypes, response to treatment and age at onset. Thus, the dog is an established and relevant model for testing a
Autor:
Dilan Paranagama, David G. Dubinski, Ahmad Naim, Ruben A. Mesa, Jingbo Yu, Andrew Bai, Shreekant Parasuraman
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
BMC Cancer
BMC Cancer
Background Patients with the myeloproliferative neoplasms (MPNs) myelofibrosis (MF), polycythemia vera (PV), and essential thrombocythemia (ET) are at increased risk for thrombotic and cardiovascular events and experience a variety of burdensome symp
Autor:
Yansen Bai, Jianzhong Wang, Jing-Jun Xiang, Ying Peng, Lige Wu, Zhuowang Chen, Xiang-Qian Yin, Wen-Hao Guo, Huan Guo, Qing Wang, Ping Xu
Publikováno v:
BMC Cancer
Background Recently studies have demonstrated that the long non-coding RNA (lncRNA) metastasis associated lung adenocarcinoma transcript 1 (MALAT1) may participate in the development and progression of lung cancer. In this study, we hypothesized that
Autor:
Tse-Ching Chen, Chao-Wei Hsu, Kung-Hao Liang, Yi-Cheng Chen, Chau-Ting Yeh, Tiffany Chen, Ming-Wei Lai
Publikováno v:
BMC Cancer
BMC Cancer, Vol 11, Iss 1, p 398 (2011)
BMC Cancer, Vol 11, Iss 1, p 398 (2011)
Background Development of the hepatitis B virus (HBV) rtA181T/sW172* mutant could occur during prolonged lamivudine (LAM) therapy, conferring cross resistance to adefovir. Recent studies demonstrated an increased oncogenic potential of this mutant in
Publikováno v:
BMC Cancer.
There is currently no consensus regarding the optimal timing for androgen suppression therapy in patients with prostate cancer that have undergone local therapy with curative intent but are proven to have node-positive disease without signs of distan
Publikováno v:
BMC Cancer, Vol 10, Iss 1, p 398 (2010)
BMC Cancer
BMC Cancer
Background The long term outcome (more than 15 years) of adjuvant treatment in patients with primary operable breast cancer has rarely been examined. Methods A randomised clinical trial of radiotherapy, chemotherapy (28 day cycles of cyclophosphamide